|
1
|
Zou AP and Cowley AW Jr: Role of nitric
oxide in the control of renal function and salt sensitivity. Curr
Hypertens Rep. 1:178–186. 1999.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Monzon CM and Garvin JL: Nitric oxide
decreases the permselectivity of the paracellular pathway in thick
ascending limbs. Hypertension. 65:1245–1250. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Garcia NH, Stoos BA, Carretero OA and
Garvin JL: Mechanism of the nitric oxide-induced blockade of
collecting duct water permeability. Hypertension. 27:679–683.
1996.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tain YL and Hsu CN: Toxic
dimethylarginines: Asymmetric dimethylarginine (ADMA) and symmetric
dimethylarginine (SDMA). Toxins (Basel). 9(92)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Jayachandran I, Sundararajan S,
Paramasivam P, Venkatesan B, Subramanian SC, Balasubramanyam M,
Mohan V and Manickam N: Association of circulatory asymmetric
dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians
and its causative role in renal cell injury. Clinical Biochem.
50:835–842. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Palm F, Onozato ML, Luo Z and Wilcox CS:
Dimethylarginine dimethylaminohydrolase (DDAH): Expression,
regulation, and function in the cardiovascular and renal systems.
Am J Physiol Heart Circ Physiol. 293:H3227–H3245. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tojo A, Welch WJ, Bremer V, Kimoto M,
Kimura K, Omata M, Ogawa T, Vallance P and Wilcox CS:
Colocalization of demethylating enzymes and NOS and functional
effects of methylarginines in rat kidney. Kidney Int. 52:1593–1601.
1997.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nijveldt RJ, Teerlink T, Siroen MP, van
Lambalgen AA, Rauwerda JA and van Leeuwen PA: The liver is an
important organ in the metabolism of asymmetrical dimethylarginine
(ADMA). Clin Nutr. 22:17–22. 2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Förstermann U and Sessa WC: Nitric oxide
synthases: Regulation and function. Eur Heart J. 33:829–37.
2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang Z, Zhu LL, Jiang HS, Chen H, Chen Y
and Dai YT: Demethylation treatment restores erectile function in a
rat model of hyperhomocysteinemia. Asian J Androl. 18:763–768.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang JG, Liu JX, Li ZH, Wang LZ, Jiang YD
and Wang SR: Dysfunction of endothelial NO system originated from
homocysteine-induced aberrant methylation pattern in promoter
region of DDAH2 gene. Chin Med J. 120:2132–7. 2007.PubMed/NCBI
|
|
12
|
Tomikawa J, Fukatsu K, Tanaka S and Shiota
K: DNA methylation-dependent epigenetic regulation of
dimethylarginine dimethylaminohydrolase 2 gene in trophoblast cell
lineage. J Biol Chem. 281:12163–12169. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li Y, Li C, Sun L, Chu G, Li J, Chen F, Li
G and Zhao Y: Role of p300 in regulating neuronal nitric oxide
synthase gene expression through nuclear factor-κB-mediated way in
neuronal cells. Neuroscience. 248:681–689. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen J, Zhang J, Shaik NF, Yi B, Wei X,
Yang XF, Naik UP, Summer R, Yan G, Xu X and Sun J: The histone
deacetylase inhibitor tubacin mitigates endothelial dysfunction by
up-regulating the expression of endothelial nitric oxide synthase.
J Biol Chem. 294:19565–19576. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen L, Fischle W, Verdin E and Greene WC:
Duration of nuclear NF-kappaB action regulated by reversible
acetylation. Science. 293:1653–1657. 2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang W, Zhao S, Ammanamanchi S, Brattain
M, Venkatasubbarao K and Freeman JW: Trichostatin A induces
transforming growth factor beta type II receptor promoter activity
and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y
complex. J Biol Chem. 280:10047–10054. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Izumi H, Ohta R, Nagatani G, Ise T,
Nakayama Y, Nomoto M and Kohno K: p300/CBP-associated factor
(P/CAF) interacts with nuclear respiratory factor-1 to regulate the
UDP-N-acetyl-alpha-d-galactosamine: Polypeptide
N-acetylgalactosaminyltransferase-3 gene. Biochem J. 373:713–722.
2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lee JS, Galvin KM, See RH, Eckner R,
Livingston D, Moran E and Shi Y: Relief of YY1 transcriptional
repression by adenovirus E1A is mediated by E1A-associated protein
p300. Genes Dev. 9:1188–1198. 1995.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li Y, Zhao Y, Li G, Wang J, Li T, Li W and
Lu J: Regulation of neuronal nitric oxide synthase exon 1f gene
expression by nuclear factor-kappaB acetylation in human
neuroblastoma cells. J Neurochem. 101:1194–1204. 2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Deng WG and Wu KK: Regulation of inducible
nitric oxide synthase expression by p300 and p50 acetylation. J
Immunol. 171:6581–6588. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Korneluk RG, Quan F and Gravel RA: Rapid
and reliable dideoxy sequencing of double-stranded DNA. Gene.
40:317–323. 1985.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sengüven B, Baris E, Oygur T and Berktas
M: Comparison of methods for the extraction of DNA from
formalin-fixed, paraffin-embedded archival tissues. Int J Med Sci.
11:494–499. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Haring M, Offermann S, Danker T, Horst I,
Peterhansel C and Stam M: Chromatin immunoprecipitation:
Optimization, quantitative analysis and data normalization. Plant
Methods. 3(11)2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yoshida M, Kijima M, Akita M and Beppu T:
Potent and specific inhibition of mammalian histone deacetylase
both in vivo and in vitro by trichostatin A. J Biol Chem.
265:17174–17179. 1990.PubMed/NCBI
|
|
26
|
Guijarro C and Egido J: Transcription
factor-kappa B (NF-kappa B) and renal disease. Kidney Int.
59:415–424. 2001.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Queisser N and Schupp N: Aldosterone,
oxidative stress, and NF-κB activation in hypertension-related
cardiovascular and renal diseases. Free Radic Biol Med. 53:314–327.
2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shang G, Gao P, Zhao Z, Chen Q, Jiang T,
Zhang N and Li H: 3,5-Diiodo-l-thyronine ameliorates diabetic
nephropathy in streptozotocin-induced diabetic rats. Biochim
Biophys Acta. 1832:674–684. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liu R, Zhong Y, Li X, Chen H, Jim B, Zhou
MM, Chuang PY and He JC: Role of transcription factor acetylation
in diabetic kidney disease. Diabetes. 63:2440–2453. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Jung YJ, Lee JE, Lee AS, Kang KP, Lee S,
Park SK, Lee SY, Han MK, Kim DH and Kim W: SIRT1 overexpression
decreases cisplatin-induced acetylation of NF-κB p65 subunit and
cytotoxicity in renal proximal tubule cells. Biochem Biophys Res
Commun. 419:206–210. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Turner BM, Birley AJ and Lavender J:
Histone H4 isoforms acetylated at specific lysine residues define
individual chromosomes and chromatin domains in Drosophila polytene
nuclei. Cell. 69:375–384. 1992.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Turner BM and Fellows G: Specific
antibodies reveal ordered and cell-cycle-related use of histone-H4
acetylation sites in mammalian cells. Eur J Biochem. 179:131–139.
1989.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Verdin E and Ott M: 50 years of protein
acetylation: From gene regulation to epigenetics, metabolism and
beyond. Nat Rev Mol Cell Biol. 16:258–264. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Gu W and Roeder RG: Activation of p53
sequence-specific DNA binding by acetylation of the p53 C-terminal
domain. Cell. 90:595–606. 1997.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kiernan RE, Vanhulle C, Schiltz L, Adam E,
Xiao H, Maudoux F, Calomme C, Burny A, Nakatani Y, Jeang KT, et al:
HIV-1 tat transcriptional activity is regulated by acetylation.
EMBO J. 18:6106–6118. 1999.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yang XJ and Seto E: HATs and HDACs: From
structure, function and regulation to novel strategies for therapy
and prevention. Oncogene. 26:5310–5318. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Huynh NC, Everts V and Ampornaramveth RS:
Histone deacetylases and their roles in mineralized tissue
regeneration. Bone Rep. 7:33–40. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhang H and Sun SC: NF-κB in inflammation
and renal diseases. Cell Biosci. 5(63)2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Henke N, Schmidt-Ullrich R, Dechend R,
Park JK, Qadri F, Wellner M, Obst M, Gross V, Dietz R, Luft FC, et
al: Vascular endothelial cell-specific NF-kappaB suppression
attenuates hypertension-induced renal damage. Circ Res.
101:268–276. 2007.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Jones LC, Tran CT, Leiper JM, Hingorani AD
and Vallance P: Common genetic variation in a basal promoter
element alters DDAH2 expression in endothelial cells. Biochem
Biophys Res Commun. 310:836–843. 2003.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Andreozzi F, Presta I, Mannino GC,
Scarpelli D, Di Silvestre S, Di Pietro N, Succurro E, Sciacqua A,
Pandolfi A, Consoli A, et al: A functional variant of the
dimethylarginine dimethylaminohydrolase-2 gene is associated with
insulin sensitivity. PLoS One. 7(e36224)2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Park JM, Jo SH, Kim MY, Kim TH and Ahn YH:
Role of transcription factor acetylation in the regulation of
metabolic homeostasis. Protein Cell. 6:804–813. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ma Z, Chalkley RJ and Vosseller K:
Hyper-O-GlcNAcylation activates nuclear factor
κ-light-chain-enhancer of activated B cells (NF-κB) signaling
through interplay with phosphorylation and acetylation. J Biol
Chem. 292:9150–9163. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Balasubramanian V, Mehta G, Jones H,
Sharma V, Davies NA, Jalan R and Mookerjee RP: Post-transcriptional
regulation of hepatic DDAH1 with TNF blockade leads to improved
eNOS function and reduced portal pressure in cirrhotic rats. Sci
Rep. 7(17900)2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hsu CN and Tain YL: Regulation of nitric
oxide production in the developmental programming of hypertension
and kidney disease. Int J Mol Sci. 20(681)2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ahmad A, Dempsey SK, Daneva Z, Azam M, Li
N, Li PL and Ritter JK: Role of Nitric Oxide in the Cardiovascular
and Renal Systems. Int J Mo Sci. 19(2605)2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lin HH, Lee TS, Lin SJ, Yeh YC, Lu TM and
Hsu CP: DDAH-2 alleviates contrast medium iopromide-induced acute
kidney injury through nitric oxide synthase. Clin Sci (Lond).
133:2361–2378. 2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wagner L, Riggleman A, Erdely A, Couser W
and Baylis C: Reduced nitric oxide synthase activity in rats with
chronic renal disease due to glomerulonephritis. Kidney Int.
62:532–536. 2002.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Staab EB, Weigel J, Xiao F, Madayiputhiya
N, Wyatt TA and Wells SM: Asymmetric dimethyl-arginine metabolism
in a murine model of cigarette smoke-mediated lung inflammation. J
Immunotoxicol. 12:273–282. 2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Lin YC, Boone M, Meuris L, Lemmens I, Van
Roy N, Soete A, Reumers J, Moisse M, Plaisance S, Drmanac R, et al:
Genome dynamics of the human embryonic kidney 293 lineage in
response to cell biology manipulations. Nat Commun.
5(4767)2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Stepanenko AA and Dmitrenko VV: HEK293 in
cell biology and cancer research: Phenotype, karyotype,
tumorigenicity, and stress-induced genome-phenotype evolution.
Gene. 569:182–190. 2015.PubMed/NCBI View Article : Google Scholar
|
